Stockreport

South Korea's ADEL signs up to $1.04 billion Alzheimer's drug development deal with Sanofi [Yahoo! Finance]

Sanofi - American Depositary Shares  (SNY) 
US:NYSE Investor Relations: sanofi.com/en/investors
PDF Under the terms of the agreement, ADEL will receive an upfront payment of $80 million, with ?additional milestone ?payments tied to development progress and commercial [Read more]